Vir Biotechnology Inc
General ticker "VIR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.1B
Vir Biotechnology Inc does not follow the US Stock Market performance with the rate: -16.1%.
Estimated limits based on current volatility of 2.3%: low 7.15$, high 7.49$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.40$, 15.15$]
- 2024-12-30 to 2025-12-30 estimated range: [6.10$, 13.76$]
Financial Metrics affecting the VIR estimates:
- Negative: Non-GAAP EPS, $ of -4.59 <= 0.10
- Negative: Operating profit margin, % of -88.81 <= 1.03
- Negative: Operating cash flow per share per price, % of -37.42 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term VIR quotes
Long-term VIR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1,095.41MM | $1,615.80MM | $86.18MM |
| Operating Expenses | $674.66MM | $782.73MM | $770.49MM |
| Operating Income | $420.75MM | $833.07MM | $-684.30MM |
| Non-Operating Income | $129.05MM | $-78.79MM | $56.11MM |
| Interest Expense | $0.00MM | $183.15MM | $0.00MM |
| R&D Expense | $448.01MM | $474.65MM | $589.67MM |
| Income(Loss) | $549.80MM | $754.28MM | $-628.19MM |
| Taxes | $21.22MM | $238.44MM | $-13.08MM |
| Profit(Loss) | $528.58MM | $515.84MM | $-615.12MM |
| Stockholders Equity | $1,431.85MM | $2,077.96MM | $1,590.24MM |
| Inventory | $8.59MM | $0.00MM | $0.00MM |
| Assets | $1,954.27MM | $2,802.09MM | $1,919.06MM |
| Operating Cash Flow | $-47.59MM | $1,663.25MM | $-778.78MM |
| Capital expenditure | $21.82MM | $68.03MM | $21.57MM |
| Investing Cash Flow | $-140.81MM | $-1,193.46MM | $164.63MM |
| Financing Cash Flow | $100.33MM | $34.76MM | $7.48MM |
| Earnings Per Share* | $4.07 | $3.89 | $-4.59 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.